 |
Avian
Influenza-fowl Pox Combined Vaccine Successfully Developed
The high-efficient and safe new type H5N1 subtype avian influenza
attenuated vaccine that has world advanced levels and recombined fowl
pox virus active carrier vaccine were successfully developed by the
¡°Animal Influenza Key Open Laboratory of MOA¡± and the ¡°State Fowl
Influenza Reference Laboratory¡± recently.
This product is a new type gene engineering avian influenza and fowl
pox combined vaccine constituted by using highly matured safe fowl
pox virus as the carrier. It has very strong antigen orientation.
After immune, it can produce protective antigen that can last 6~10
months, which is superior to the performance similar vaccines in the
world. It can be extensively applied to in fowls (including water
fowls) to control high pathogenic H5 sub-type avian influenza.
Source: www.cav.net.cn
|
|
|
